Diagnostics company Thyrocare Technologies, which recently concluded its IPO, will list its shares on the bourses tomorrow.
“Effective from Monday, May 9, 2016, the equity shares of Thyrocare Technologies shall be listed and admitted to dealings on the exchange,” BSE had said in a notice earlier this week.
The initial public offering (IPO) of Thyrocare was oversubscribed 73.55 times in a price band of Rs 420-446.
The issue was open for bidding from April 27-29.
The firm, which runs a diagnostics laboratory chain, has come out with a public issue of up to 10,744,708 shares.
The shares are proposed to be listed on the NSE and BSE.
JM Financial Institutional Securities, Edelweiss Financial Services and ICICI Securities managed the issue.
Thyrocare competes with diagnostics chains such as Dr Lal PathLabs, SRL Diagnostics, Metropolis Healthcare and Apollo Clinic.
Many healthcare firms like Alkem Laboratories, Dr Lal PathLabs and Narayana Hrudayalaya came out with their IPOs last year, while HealthCare Global Enterprises got listed on the stock exchanges in March.